T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

Peter Tsang, New York

Albany Med College, Albany

Univ of Pittsburgh, Pittsburgh

MCP Hahnemann Univ, Philadelphia

Pennsylvania Oncology and Hematology Associates, Philadelphia

Whitman Walker Clinic/Elizabeth Taylor Med Ctr, Washington D.C.

AIDS Research Consortium of Atlanta, Atlanta

IDC Research Initiative, Altamonte Springs

Steinhart Medical Associates, Miami

Vanderbilt Univ Med Ctr, Nashville

Case Western Reserve Univ / AIDS Clinical Trials Unit, Cleveland

Regions Hosp, Saint Paul

Trevor Slom, Chicago

Nicholas Bellos, Dallas

Univ of Texas / Thomas Street Clinic, Houston

Univ of Texas Med Branch, Galveston

Univ of Colorado Health Sciences Ctr, Denver

Phoenix Body Positive, Phoenix

Pacific Oaks Med Group, Beverly Hills

Univ of California, San Diego, San Diego

San Francisco Gen Hosp, San Francisco

San Francisco VA Med Ctr, San Francisco

Oregon Health Sciences Univ, Portland

Univ of Washington / AIDS Clinical Trial Unit, Seattle

Vancouver Clinic, Vancouver

Columbia Presbyterian Med Ctr, New York

Univ of North Carolina / SOCA, Chapel Hill

Univ of Alabama at Birmingham, Birmingham

Univ of Cincinnati, Cincinnati

Indiana Univ Hosp, Indianapolis

AIDS Healthcare Foundation, Los Angeles

New England Med Ctr, Boston

Massachusetts Gen Hosp, Boston

Community Research Initiative of New England, Brookline

Toronto Gen Hosp, Toronto

Centre Hospitalier de la Universite de Montreal (CHUM), Montreal

Clinique Medicale L'Actuele, Montreal